Skip to main content

Lucira Health, Inc.

LHDXDelisted Apr 12, 2023
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0001652724

Lucira Health, Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Mar 13, 2023; 29 institutions reported holding it in 13F filings for Q4 2022, worth $1.04M in total; no superinvestor held it.

Q3 2023 vs. Q2 2023

How the institutions holding Lucira Health, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of LHDX: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders10−1
Shares22.8K0−22.8K (−100.0%)
Value$545$0−$545 (−100.0%)

New holders (0)

Institutions that held Lucira Health, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

None.

Sold out (1)

Institutions that held Lucira Health, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of LHDX in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Resolute Partners Group22,800$545